These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16585115)

  • 21. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia.
    Mengual L; Roura P; Serra M; Montasell M; Prieto G; Bonet S
    Cardiovasc Diabetol; 2010 Mar; 9():14. PubMed ID: 20350315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
    Jaussi A; Noll G; Meier B; Darioli R
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of care for patients with type 2 diabetes in general practice according to patients' ethnic background: a cross-sectional study from Oslo, Norway.
    Tran AT; Diep LM; Cooper JG; Claudi T; Straand J; Birkeland K; Ingskog W; Jenum AK
    BMC Health Serv Res; 2010 May; 10():145. PubMed ID: 20507647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes guidelines: easier to preach than to practise?
    Bryant W; Greenfield JR; Chisholm DJ; Campbell LV
    Med J Aust; 2006 Sep; 185(6):305-9. PubMed ID: 16999670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in body mass index, glycosylated hemoglobin A1C, blood pressure, and LDL-cholesterol among type 2 diabetes patients in Malaysia: A population-based longitudinal study.
    Wan KS; Moy FM; Mustapha FI; Ismail M; Hairi NN
    J Diabetes; 2021 Nov; 13(11):915-929. PubMed ID: 34142456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of Diabetes Care in Germany Improved from 2000 to 2007 to 2014, but Improvements Diminished since 2007. Evidence from the Population-Based KORA Studies.
    Laxy M; Knoll G; Schunk M; Meisinger C; Huth C; Holle R
    PLoS One; 2016; 11(10):e0164704. PubMed ID: 27749939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.
    Ji L; Hu D; Pan C; Weng J; Huo Y; Ma C; Mu Y; Hao C; Ji Q; Ran X; Su B; Zhuo H; Fox KA; Weber M; Zhang D; ;
    Am J Med; 2013 Oct; 126(10):925.e11-22. PubMed ID: 23810406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
    Eeg-Olofsson K; Zethelius B; Gudbjörnsdottir S; Eliasson B; Svensson AM; Cederholm J
    Diab Vasc Dis Res; 2016 Jul; 13(4):268-77. PubMed ID: 27190080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of type 2 diabetes in Western Australian metropolitan general practice.
    Kamien M; Ward AM; Mansfield F; Fatovich B; Mather C; Anstey K
    Diabetes Res Clin Pract; 1994 Dec; 26(3):197-208. PubMed ID: 7736900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice.
    Renders CM; Valk GD; Franse LV; Schellevis FG; van Eijk JT; van der Wal G
    Diabetes Care; 2001 Aug; 24(8):1365-70. PubMed ID: 11473071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial.
    Eliraqi GM; Vistisen D; Lauritzen T; Sandbaek A; Jørgensen ME; Faerch K
    Diabet Med; 2015 Aug; 32(8):1085-9. PubMed ID: 25819139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report.
    Ferrario CM; Joyner J; Colby C; Exuzides A; Moore M; Simmons D; Bestermann W; Frech-Tamas F
    Vasc Health Risk Manag; 2013; 9():391-400. PubMed ID: 23901282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASPIRE-2-PREVENT: a survey of lifestyle, risk factor management and cardioprotective medication in patients with coronary heart disease and people at high risk of developing cardiovascular disease in the UK.
    Kotseva K; Jennings CS; Turner EL; Mead A; Connolly S; Jones J; Bowker TJ; Wood DA;
    Heart; 2012 Jun; 98(11):865-71. PubMed ID: 22581735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factor management in a contemporary Australian population at increased cardiovascular disease risk.
    Campbell DJ; Coller JM; Gong FF; McGrady M; Prior DL; Boffa U; Shiel L; Liew D; Wolfe R; Owen AJ; Krum H; Reid CM
    Intern Med J; 2018 Jun; 48(6):688-698. PubMed ID: 29136331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between socioeconomic deprivation and metabolic/cardiovascular risk factors in a cohort of patients with type 2 diabetes mellitus.
    O'Kane MJ; McMenamin M; Bunting BP; Moore A; Coates VE
    Prim Care Diabetes; 2010 Dec; 4(4):241-9. PubMed ID: 20869343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Microalbuminuria Education Medication and Optimisation (MEMO) study: 4 years follow-up of multifactorial intervention in high-risk individuals with type 2 diabetes.
    Crasto W; Morrison AE; Gray LJ; John E; Jarvis J; Brela J; Khunti K; Troughton J; Lawrence IG; McNally PG; Davies MJ
    Diabet Med; 2020 Feb; 37(2):286-297. PubMed ID: 31505051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007].
    Voorham J; Haaijer-Ruskamp FM; van der Meer K; de Zeeuw D; Wolffenbuttel BH; Hoogenberg K; Denig P
    Ned Tijdschr Geneeskd; 2010; 154():A775. PubMed ID: 20132579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Socioeconomic position and cardiovascular risk factors among people with screen-detected Type 2 DM: six-year follow-up of the ADDITION-Denmark trial.
    Dalsgaard EM; Vestergaard M; Skriver MV; Borch-Johnsen K; Lauritzen T; Sandbaek A
    Prim Care Diabetes; 2014 Dec; 8(4):322-9. PubMed ID: 24613817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.